Search

everythinglearnresearchcommunity

for

Search:↓

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Ebastine may help regrow hair in alopecia areata patients.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

Alopecia areata involves complex immune activity, mainly Th1, with potential benefits from broader immune treatments.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

People with alopecia areata are more likely to have other immune-related conditions.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Alopecia areata may be linked to atopic diseases like eczema, asthma, and allergies.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Acne patients' skin, both with and without lesions, shows a strong immune response and higher antimicrobial activity.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Langerhans cells and melanocytes migrate to the skin and hair follicles during early human development.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Low-level laser therapy may help with hair regrowth in alopecia areata but its effectiveness for psoriasis and atopic dermatitis needs more research.

The conclusion is that understanding the complex relationship between allergies, autoimmunity, and psychological factors is key to treating skin disorders with itching.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Leflunomide is more likely to help treat alopecia areata than cause it.

Hair follicles prevent NK cell attacks to avoid hair loss.